| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |